RESEARCHER PROFILE
Michael Rutledge DeBaun
← Back to Vanderbilt University
M
Vanderbilt University
Michael Rutledge DeBaun works in Hemoglobinopathies and Related Disorders, Blood groups and transfusion, Acute Ischemic Stroke Management, Advanced MRI Techniques and Applications, Malaria Research and Control. Recorded institutional associations include University of California, Los Angeles, Vanderbilt University, Children's Hospital Colorado.
605Publications
26,688Citations
82H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
2021 · 2,192 citationsAssociation of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19
2003 · 916 citationsManagement of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association
2019 · 797 citationsInherited causes of clonal haematopoiesis in 97,691 whole genomes
2020 · 728 citationsControlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
2014 · 544 citationsAssessing the contribution of rare variants to complex trait heritability from whole-genome sequence data
2022 · 513 citationsRisk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry
1998 · 437 citationsAmerican Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults
2020 · 434 citationsLoss of imprinting of a paternally expressed transcript, with antisense orientation to K V LQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
1999 · 358 citationsSilent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia
2012 · 346 citationsSilent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis
1999 · 310 citationsSilent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease
2001 · 289 citationsPoor school and cognitive functioning with silent cerebral infarcts and sickle cell disease
2001 · 279 citationsEpigenetic Alterations of H19 and LIT1 Distinguish Patients with Beckwith-Wiedemann Syndrome with Cancer and Birth Defects
2002 · 276 citationsCentral nervous system complications and management in sickle cell disease
2016 · 263 citationsDynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale
2020 · 263 citationsSilent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease
2010 · 262 citationsAsthma is associated with acute chest syndrome and pain in children with sickle cell anemia
2006 · 253 citationsRisk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke
2002 · 247 citationsMalignant peripheral nerve sheath tumors in neurofibromatosis 1
2000 · 246 citationsRacial disparity in the frequency of recurrence of preterm birth
2007 · 223 citationsAssociation between Beckwith-Wiedemann syndrome and assisted reproductive technology: A case series of 19 patients
2005 · 219 citationsAssociated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
2011 · 211 citationsClonal haematopoiesis and risk of chronic liver disease
2023 · 210 citationsDiscontinuing penicillin prophylaxis in children with sickle cell anemia
1995 · 207 citations